Welcome to KidneyX

Learn More

What is KidneyX?

The Kidney Innovation Accelerator (KidneyX) is a public-private partnership between the US Department of Health and Human Services and the American Society of Nephrology to accelerate innovation in the prevention, diagnosis, and treatment of kidney diseases. KidneyX seeks to improve the lives of the 850 million people worldwide currently affected by kidney diseases by accelerating the development of drugs, devices, biologics and other therapies across the spectrum of kidney care including:

Prevention

Diagnostics

Treatment

Learn More

How will KidneyX Succeed?

Building off the success of similar public-private accelerators, KidneyX will engage a community of researchers, innovators, and investors to bring breakthrough therapies to patients by:

Development

Driving patient access to disruptive technologies via competitive, non-dilutive funding to innovators.

Coordination

Providing a clearer and less expensive path to bringing products to patients and their families.

Urgency

Creating a sense of urgency by spotlighting the immediate needs of patients and their families.

Learn More

Kidney Disease Statistics

0

A typical in-center hemodialysis patient spends 12 hours a week attached to a machine

Source: Report to Congressional Requesters: National Institutes of Health – Kidney Disease Research Funding and Priority Setting; United States Government Accountability Office; December 2016.

0

Among patients ages 18-54 years old at the start of dialysis, 93% were classified as disabled

Source: Erickson K, et al. Employment among Patients Starting Dialysis in the United States. Clinc J. Am Soc Nephrol 13: 265-273, 2018.

0

Each year, more than 100,000 Americans begin hemodialysis as a result of kidney failure

Source: United States Renal Data System. 2017 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2017.

0

40 Million adult Americans are currently classified as having chronic kidney disease

Source: Report to Congressional Requesters: National Institutes of Health – Kidney Disease Research Funding and Priority Setting; United States Government Accountability Office; December 2016.

0

Every day 13 patients die waiting for a kidney transplant

Source: Mitchell K. For Transplant Patients, 'This is Your Statue of Liberty'. GW Magazine. http://magazine.gwu.edu/for-transplant-patients. Published December 2, 2016. Accessed March 2018.

0

Of Stage 4 CKD patients, 48% were unaware of their severe CKD

Source: United States Renal Data System. 2017 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2017.

0

African-Americans are 3.5x more likely to develop kidney failure

Source: Kidney Disease Statistics for the United States. National Institute of Diabetes and Digestive Kidney Diseases. https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease. Published December 2016. Accessed March 2018.

0

Hispanics are 1.5x more likely to develop kidney failure

Source: Kidney Disease Statistics for the United States. National Institute of Diabetes and Digestive Kidney Diseases. https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease. Published December 2016. Accessed March 2018.

Get Involved

Interested in being part of the KidneyX solution? Join the mailing list:

Subscribe

Learn More

KidneyX In The News

Alio Inc., received FDA 510(k) clearance for its noninvasive remote monitoring system

Alio Inc. is developing a technology to monitor ESKD patients undergoing hemodialysis.

May 3, 2022

Public Comment Period Now Open for Human-Centered Design Toolkit for Kidney Failure

KHI is releasing a draft version of its Human-Centered Design Toolkit for Kidney Failure for public comment. The toolkit provides pre-clinical innovators and early-stage start-ups developing kidney replacement therapies with empathy tools to facilitate their interactions with people with kidney failure, enable market segmentation, and provide a framework for a customer requirements document.

May 3, 2022

Relavo, Inc. Awarded Grant from the National Science Foundation

KidneyX's Redesign Dialysis Phase 2 winner Relavo, Inc. received $1M from the National Science Foundation Small Business Innovation Research (SBIR) grant.

April 27, 2022

United States Ambassador Convenes Forum on Enhancing Kidney Health in the Pacific

The U.S. Ambassador Joseph Cella hosted Pacific health officials and clinicians for a dialogue on the prevention, diagnosis, and treatment of kidney disease. The conversation generated ideas and inspiration for new ways that the United States, Fiji, and other Pacific island countries can work together to overcome health challenges.

August 26, 2020

VenoStent has a new technology to improve outcomes for dialysis patients

Timothy Bouré and his co-founder Geoffrey Lucks were both near broke when they moved to Dallas to join the first accelerator they entered after forming VenoStent, a company that aims to improve outcomes for dialysis patients.

August 9, 2020

View All »

Want to Learn More?

Contact KidneyX

Individuals that are interested in being part of the KidneyX solution are encouraged to contact KidneyX at kidneyx@asn-online.org to be placed on a mailing list.

Follow on Twitter: @Kidney_X

202-640-4660